D-1214-2018 Class III Terminated
FDA drug recall D-1214-2018 was initiated by LUPIN SOMERSET on Aug 23, 2018 and is designated Class III. Reason for recall: Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month… The recall status is terminated (terminated Oct 14, 2022). Affected quantity: 4716 bottle.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 26, 2018
- Initiation Date
- Aug 23, 2018
- Termination Date
- Oct 14, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4716 bottle
Product description
Morphine Sulfate Extended-Release Tablets, 30 mg, 100-count bottle, Rx only, Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202, NDC 43386-541-01
Reason for recall
Failed Impurities/Degradation Specifications: Morphine Sulfate Extended Release Tablets are being recalled due to out of Specification Result noticed for Morphinone Sulfate impurity during 3 month stability analysis and during retain testing.
Distribution pattern
U.S.A. Nationwide
Code information
Lot# S800232, Exp 2/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1214-2018
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026